Illumina, Inc. (ILMN) EVP Sells $484,660.00 in Stock

Illumina, Inc. (NASDAQ:ILMN) EVP Marc Stapley sold 2,000 shares of the firm’s stock in a transaction on Wednesday, January 17th. The shares were sold at an average price of $242.33, for a total transaction of $484,660.00. Following the transaction, the executive vice president now directly owns 29,815 shares of the company’s stock, valued at approximately $7,225,068.95. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Marc Stapley also recently made the following trade(s):

  • On Monday, December 4th, Marc Stapley sold 2,000 shares of Illumina stock. The shares were sold at an average price of $219.88, for a total transaction of $439,760.00.
  • On Wednesday, November 15th, Marc Stapley sold 2,000 shares of Illumina stock. The shares were sold at an average price of $205.48, for a total transaction of $410,960.00.
  • On Thursday, October 26th, Marc Stapley sold 2,000 shares of Illumina stock. The shares were sold at an average price of $206.88, for a total transaction of $413,760.00.

Shares of Illumina, Inc. (NASDAQ:ILMN) opened at $243.55 on Friday. The company has a quick ratio of 3.73, a current ratio of 4.22 and a debt-to-equity ratio of 0.41. The company has a market cap of $35,560.00, a price-to-earnings ratio of 45.95, a price-to-earnings-growth ratio of 3.27 and a beta of 0.79. Illumina, Inc. has a twelve month low of $156.50 and a twelve month high of $248.97.

Illumina (NASDAQ:ILMN) last posted its quarterly earnings results on Tuesday, October 24th. The life sciences company reported $1.11 EPS for the quarter, topping analysts’ consensus estimates of $0.99 by $0.12. The business had revenue of $714.00 million during the quarter, compared to analysts’ expectations of $692.77 million. Illumina had a net margin of 30.34% and a return on equity of 19.42%. The business’s quarterly revenue was up 17.6% on a year-over-year basis. During the same period last year, the company posted $0.97 earnings per share. equities analysts predict that Illumina, Inc. will post 3.77 EPS for the current fiscal year.

Several research firms have recently issued reports on ILMN. Deutsche Bank set a $275.00 price target on shares of Illumina and gave the company a “buy” rating in a research note on Tuesday, January 16th. BTIG Research reissued a “hold” rating on shares of Illumina in a research note on Tuesday, January 16th. BidaskClub raised shares of Illumina from a “hold” rating to a “buy” rating in a research note on Friday, January 5th. William Blair downgraded shares of Illumina from an “outperform” rating to a “market perform” rating in a research note on Friday, January 5th. Finally, Evercore ISI started coverage on shares of Illumina in a research note on Wednesday, January 3rd. They set an “outperform” rating and a $250.00 target price for the company. One research analyst has rated the stock with a sell rating, nine have given a hold rating and fourteen have issued a buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $220.13.

A number of large investors have recently bought and sold shares of ILMN. Federated Investors Inc. PA grew its holdings in Illumina by 46.2% in the second quarter. Federated Investors Inc. PA now owns 3,704 shares of the life sciences company’s stock worth $642,000 after purchasing an additional 1,171 shares during the period. Neuberger Berman Group LLC grew its holdings in Illumina by 35.7% in the second quarter. Neuberger Berman Group LLC now owns 4,893 shares of the life sciences company’s stock worth $849,000 after purchasing an additional 1,286 shares during the period. Los Angeles Capital Management & Equity Research Inc. acquired a new stake in Illumina in the second quarter worth $226,000. Riverhead Capital Management LLC grew its holdings in Illumina by 20.7% in the second quarter. Riverhead Capital Management LLC now owns 2,313 shares of the life sciences company’s stock worth $401,000 after purchasing an additional 397 shares during the period. Finally, Nationwide Fund Advisors grew its holdings in Illumina by 9.6% in the second quarter. Nationwide Fund Advisors now owns 101,545 shares of the life sciences company’s stock worth $17,620,000 after purchasing an additional 8,895 shares during the period. Institutional investors and hedge funds own 91.60% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Illumina, Inc. (ILMN) EVP Sells $484,660.00 in Stock” was published by Ticker Report and is owned by of Ticker Report. If you are accessing this piece on another domain, it was stolen and republished in violation of US & international copyright & trademark laws. The original version of this piece can be read at https://www.tickerreport.com/banking-finance/3148726/illumina-inc-ilmn-evp-sells-484660-00-in-stock.html.

About Illumina

Illumina, Inc (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of its core operations.

Insider Buying and Selling by Quarter for Illumina (NASDAQ:ILMN)

Receive News & Ratings for Illumina Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Illumina and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


© 2006-2018 Ticker Report. Google+.